These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 4334504)
1. The occurrence of IgM and complement factors along myelin sheaths of peripheral nerves. An immunohistochemical study of the Guillain-Barré syndrome. Preliminary communication. Luijten JA; Baart de la Faille-Kuyp J Neurol Sci; 1972 Feb; 15(2):219-24. PubMed ID: 4334504 [No Abstract] [Full Text] [Related]
2. Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome. Tse KS; Arbesman CE; Tomasi TB; Tourville D Clin Exp Immunol; 1971 Jun; 8(6):881-7. PubMed ID: 4997072 [TBL] [Abstract][Full Text] [Related]
3. The action of Guillain-Barrĕ syndrome serum on myelin. A tissue culture and electron microscopic analysis. Dubois-Dalcq M; Buyse M; Buyse G; Gorce F J Neurol Sci; 1971 May; 13(1):67-83. PubMed ID: 5105788 [No Abstract] [Full Text] [Related]
4. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. Monaco S; Bonetti B; Ferrari S; Moretto G; Nardelli E; Tedesco F; Mollnes TE; Nobile-Orazio E; Manfredini E; Bonazzi L N Engl J Med; 1990 Mar; 322(10):649-52. PubMed ID: 1689461 [TBL] [Abstract][Full Text] [Related]
5. Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barré syndrome: quantitation, kinetics, and clinical correlation. Koski CL Ann N Y Acad Sci; 1987; 505():319-25. PubMed ID: 3479928 [No Abstract] [Full Text] [Related]
13. Cellular hypersensitivity to basic myelin (P2) protein in the Guillain-Barré syndrome. Sheremata W; Colby S; Karkhanis Y; Eylar EH Can J Neurol Sci; 1975 May; 2(2):87-90. PubMed ID: 165869 [TBL] [Abstract][Full Text] [Related]
14. [Immunofluorescence studies of antigenic properties of myelin]. Wajgt A Neurol Neurochir Pol; 1972; 6(1):9-14. PubMed ID: 4553034 [No Abstract] [Full Text] [Related]
15. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies. Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte transformation in the Guillain-Barré syndrome. Knowles M; Currie S; Saunders M; Walton JN; Field EJ Lancet; 1969 Nov; 2(7631):1168-70. PubMed ID: 4187205 [No Abstract] [Full Text] [Related]
17. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. Yako K; Kusunoki S; Kanazawa I J Neurol Sci; 1999 Oct; 168(2):85-9. PubMed ID: 10526188 [TBL] [Abstract][Full Text] [Related]
18. Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin; effect of plasma exchange. Ernerudh J; Brodtkorb E; Olsson T; Vedeler CA; Nyland H; Berlin G J Neuroimmunol; 1986 May; 11(3):171-8. PubMed ID: 3007573 [TBL] [Abstract][Full Text] [Related]
19. Reactivity of sera and isolated monoclonal IgM from patients with Waldenström's macroglobulinaemia with peripheral nerve myelin. Harbs H; Arfmann M; Frick E; Hörmann C; Wurster U; Patzold U; Stark E; Deicher H J Neurol; 1985; 232(1):43-8. PubMed ID: 2582095 [TBL] [Abstract][Full Text] [Related]
20. Human monoclonal IgM autoantibodies with restricted antigenic specificity for myelin express unrelated idiotypes. Kahn SN J Neurol Sci; 1985 Jul; 69(3):161-70. PubMed ID: 2411877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]